Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Felix Ehret

Showing results (101-110 of 120) with videos related to

Pageof 12
Sort By:
Journal of Neuro-Oncology|February 11, 2025
Clinical characteristics and outcomes in leptomeningeal disease with or without brain metastasis: insights from an explorative data analysis of the Charité LMD registryDavid Wasilewski, Chiara Eitner, Rober Ates, et al.
Journal of Applied Clinical Medical Physics|April 9, 2026
Reirradiation treatment effects in the clinic (ReTEC) proposal - proof of concept based on spinal cord dose tolerance for reirradiation with stereotactic body radiotherapyJimm Grimm, Anand Mahadevan, Olusola Obayomi-Davies, et al.
Neuro-Oncology|February 3, 2023
Adult intracranial ependymoma-relevance of DNA methylation profiling for diagnosis, prognosis, and treatmentMalte Träger, Leonille Schweizer, Eilís Pérez, et al.
Clinical and Translational Radiation Oncology|March 19, 2026
Stereotactic body radiotherapy in patients with bone oligometastases from breast cancer - results from a European multicenter cohort studySebastian Schäfer, Isabell Seiler, Lena Kästner, et al.
International Journal of Cancer|February 18, 2026
Oxaliplatin-induced neuropathy after total neoadjuvant therapy for rectal cancer: Dose-response relationship and impact on quality of lifeGeorg W Wurschi, Andreas Hinz, Melanie Schneider, et al.
Clinical and Translational Radiation Oncology|February 18, 2026
Clinical and treatment-related predictors of complete response after total neoadjuvant therapy for rectal cancer in a large multicenter analysisGeorg W Wurschi, Melanie Schneider, Jan-Niklas Becker, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|October 12, 2025
Short-course radiotherapy versus long-course chemoradiotherapy in total neoadjuvant therapy of rectal cancer - A multicenter analysis of early outcomes and toxicityGeorg Wurschi, Miriam Kesselmeier, Melanie Schneider, et al.
Neuro-Oncology|November 19, 2025
A framework for using DNA methylation-based modelling for the clinical management of cranial meningiomaAlexander P Landry, Justin Z Wang, Vikas Patil, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|November 10, 2025
Impact of target volume and dose concepts on the outcomes of prostate cancer patients treated with stereotactic body radiotherapy for spinal metastases - a European multicenter cohort studyIsabell Seiler, Sebastian Schäfer, Camilla von Wachter, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|March 16, 2026
Outcomes of stereotactic body radiotherapy for bone oligometastases in older patients - A European multicenter cohort studyFranziska Nägler, Sebastian Schäfer, Isabell Seiler, et al.
Pageof 12

Showing results (101-110 of 120) with videos related to

Sort By:
Pageof 12
Journal of Neuro-Oncology|February 11, 2025
Clinical characteristics and outcomes in leptomeningeal disease with or without brain metastasis: insights from an explorative data analysis of the Charité LMD registryDavid Wasilewski, Chiara Eitner, Rober Ates, et al.
Journal of Applied Clinical Medical Physics|April 9, 2026
Reirradiation treatment effects in the clinic (ReTEC) proposal - proof of concept based on spinal cord dose tolerance for reirradiation with stereotactic body radiotherapyJimm Grimm, Anand Mahadevan, Olusola Obayomi-Davies, et al.
Neuro-Oncology|February 3, 2023
Adult intracranial ependymoma-relevance of DNA methylation profiling for diagnosis, prognosis, and treatmentMalte Träger, Leonille Schweizer, Eilís Pérez, et al.
Clinical and Translational Radiation Oncology|March 19, 2026
Stereotactic body radiotherapy in patients with bone oligometastases from breast cancer - results from a European multicenter cohort studySebastian Schäfer, Isabell Seiler, Lena Kästner, et al.
International Journal of Cancer|February 18, 2026
Oxaliplatin-induced neuropathy after total neoadjuvant therapy for rectal cancer: Dose-response relationship and impact on quality of lifeGeorg W Wurschi, Andreas Hinz, Melanie Schneider, et al.
Clinical and Translational Radiation Oncology|February 18, 2026
Clinical and treatment-related predictors of complete response after total neoadjuvant therapy for rectal cancer in a large multicenter analysisGeorg W Wurschi, Melanie Schneider, Jan-Niklas Becker, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|October 12, 2025
Short-course radiotherapy versus long-course chemoradiotherapy in total neoadjuvant therapy of rectal cancer - A multicenter analysis of early outcomes and toxicityGeorg Wurschi, Miriam Kesselmeier, Melanie Schneider, et al.
Neuro-Oncology|November 19, 2025
A framework for using DNA methylation-based modelling for the clinical management of cranial meningiomaAlexander P Landry, Justin Z Wang, Vikas Patil, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|November 10, 2025
Impact of target volume and dose concepts on the outcomes of prostate cancer patients treated with stereotactic body radiotherapy for spinal metastases - a European multicenter cohort studyIsabell Seiler, Sebastian Schäfer, Camilla von Wachter, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|March 16, 2026
Outcomes of stereotactic body radiotherapy for bone oligometastases in older patients - A European multicenter cohort studyFranziska Nägler, Sebastian Schäfer, Isabell Seiler, et al.
Pageof 12